Description de l'entreprise
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Conseil d'administration & Conseil de surveillance
| PDG |
| Daniel O’Day |
| Conseil d'administration |
| Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey |
| Conseil de surveillance |
| Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez |
Données de l'entreprise
| Nom: |
Gilead Sciences Inc. |
| Adresse: |
333 Lakeside Drive,Foster City, California 94404, USA |
| Téléphone: |
+1-650-574-3000 |
| Fax: |
+1-650-578-9264 |
| Courriel: |
corporate_developmen...ad.com
corporate_development@gilead.com
|
| Internet: |
www.gilead.com |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
99.89% |
| IPO date: |
22/01/1992 |
